The global pneumonia treatment drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to boost the market growth during the forecast period includes the surge in the incidence of pneumonia. Furthermore, the rise in the prevalence of community-acquired pneumonia, especially in younger individuals is another major factor, that is anticipated to fuel the growth of the market in the coming years. In addition, the surge in R&D related to the treatment methods is also expected to drive market growth. However, a lack of awareness regarding preventive vaccines is expected to hinder the growth of the market. On the contrary, the surge in investments in the development of newer products that can be used as therapeutics for pneumonia is anticipated to create opportunities for the growth of the global pneumonia therapeutics market during the forecast period.

Pneumonia Treatment Drugs are used for the prevention and treatment of patients suffering from pneumonia. Pneumonia is an infection that causes inflammation in individuals’ lungs, especially the alveoli. The alveoli get filled up with fluid or pus. The symptoms in an individual affected with pneumonia include fever, chills, cough, and trouble breathing. Furthermore, other common causes of viral pneumonia include respiratory syncytial virus (RSV), influenza, and SARS-CoV-2. In addition, the commonly observed cause of bacterial pneumonia is Streptococcus pneumoniae (pneumococcus). In January 2021, The World Health Organization declared the COVID-19 outbreak a public health emergency of international concern. Individual suffering COVID-19 is highly susceptible to pneumonia, thus causing shortness of breath and filling of mucus in the alveoli. This is expected to propel the growth of the global pneumonia treatment drugs market during the forecast period. 

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Drug Type 

o By Distribution Channel

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape: Pfizer Inc., Mylan NV, and Abbott Laboratories, among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Pneumonia Treatment Drugs Market Report by Segment

By Drug Type

• Quinolone

• Macrolide

• Aminopenicilin

• Cephalosporins

• Glycopeptide Antibiotics

• Others

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Global Pneumonia Treatment Drugs Market by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa